1 Min Read
April 5 (Reuters) - Kura Oncology Inc:
* Kura Oncology Inc says presents preclinical data demonstrating significant anti-tumor activity of ko-947 and ko-539 Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.